Form 4: STERIS plc: Executive Karen L. Burton Reports Share Transactions

STERIS plc executive Karen L. Burton reported transactions involving ordinary shares, including the withholding of shares for tax purposes and details on restricted share vesting schedules.

Summary

• Karen L. Burton, Sr. Vice Pres., CFO of STERIS plc, reported a transaction on June 4, 2026.
• 90 ordinary shares were withheld to cover taxes required by employment or tax laws.
• These withheld shares were part of 306 restricted shares that vested on June 4, 2026.
• The value of the withheld shares was based on the NYSE closing market price on June 4, 2026, which was $212.24 per share.
• Following the transaction, Ms. Burton beneficially owns 13,184 ordinary shares directly.
• As of June 8, 2026, 9,282 of these ordinary shares remain restricted, with various lapse dates extending to June 4, 2029.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine executive share transactions and tax withholdings without indicating significant positive or negative developments for the company.

Positives

• The transaction reflects the settlement of restricted stock awards, indicating continued executive compensation and alignment with company performance.
• The withholding of shares for tax purposes is a standard procedure that ensures compliance with tax obligations.

Negatives

• A portion of vested shares (90 out of 306) were withheld, reducing the immediate net shares received by the executive.

Risks

• The vesting schedule for the remaining restricted shares indicates a phased release, which could be impacted by future company performance or executive tenure.
• The value of the restricted shares is subject to market fluctuations until they fully vest.

Future Outlook

The filing details a schedule for the lapse of restrictions on 9,282 ordinary shares, with tranches vesting on various dates through June 4, 2029. This indicates a structured approach to executive equity compensation over the next several years.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine for executives and provide transparency into insider holdings and transactions. The details of restricted stock vesting and tax withholding are standard practices within the healthcare technology and services industry, reflecting common executive compensation structures.

Stakeholder Impact

• Shareholders: The transaction provides insight into executive compensation and equity holdings, which can indirectly influence investor confidence.
• Employees: The tax withholding mechanism highlights the tax implications associated with executive equity compensation.
• Management: Karen L. Burton's continued equity holdings and vesting schedule demonstrate ongoing commitment and alignment with the company.

Next Steps

• Monitoring the vesting schedule of the remaining 9,282 restricted shares.
• Observing future Form 4 filings for any additional transactions by Karen L. Burton or other executives.

Key Dates

Keywords

STERIS plc, STE, Form 4, Insider Transaction, Karen L. Burton, CFO, Restricted Stock, Share Withholding, Vesting Schedule, Beneficial Ownership